Rohan Kalyan Rej

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Positive Breast Cancer

Endoplasmic Reticulum

Clinical Evaluation

Top Venues

Journal of medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Changwei Wang, Mi Wang, Yu Wang, Rohan Kalyan Rej, Angelo Aguilar, Tianfeng Xu, Longchuan Bai, Jelena Tošović, Donna McEachern, Qiuxia Li, Farzad Sarkari, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9. Journal of medicinal chemistry (2024)
Changwei Wang, Mi Wang, Yu Wang, Rohan Kalyan Rej, Angelo Aguilar, Tianfeng Xu, Longchuan Bai, Jelena Tošović, Donna McEachern, Qiuxia Li, Farzad Sarkari, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9. Journal of medicinal chemistry 67 (16) (2024)
Rohan Kalyan Rej, Joyeeta Roy, Srinivasa Rao Allu
Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions. Cancers 16 (3) (2024)
Changwei Wang, Mi Wang, Yu Wang, Rohan Kalyan Rej, Angelo Aguilar, Tianfeng Xu, Longchuan Bai, Jelena Tošović, Donna McEachern, Qiuxia Li, Farzad Sarkari, Bo Wen, Duxin Sun, Shaomeng Wang
Discovery of CW-3308 as a Potent, Selective, and Orally Efficacious PROTAC Degrader of BRD9. Journal of medicinal chemistry 67 (16) (2024)
Rohan Kalyan Rej, Joyeeta Roy, Srinivasa Rao Allu
Therapies for the Treatment of Advanced/Metastatic Estrogen Receptor-Positive Breast Cancer: Current Situation and Future Directions. Cancers 16 (3) (2024)
Rohan Kalyan Rej, Srinivasa Rao Allu, Joyeeta Roy, Ranjan Kumar Acharyya, I N Chaithanya Kiran, Yesu Addepalli, V Dhamodharan
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Rohan Kalyan Rej, Srinivasa Rao Allu, Joyeeta Roy, Ranjan Kumar Acharyya, I N Chaithanya Kiran, Yesu Addepalli, V Dhamodharan
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Canhui Zheng, Rohan Kalyan Rej, Mi Wang, Liyue Huang, Ester Fernandez-Salas, Chao-Yie Yang, Shaomeng Wang
Discovery of Pyrrolo[2,3- c ]pyridines as Potent and Reversible LSD1 Inhibitors. ACS medicinal chemistry letters 14 (10) (2023)
Zhixiang Chen, Biao Hu, Rohan Kalyan Rej, Dimin Wu, Ranjan Kumar Acharyya, Mingliang Wang, Tianfeng Xu, Jianfeng Lu, Hoda Metwally, Yu Wang, Donna McEachern, Longchuan Bai, Christina L Gersch, Meilin Wang, Wenjing Zhang, Qiuxia Li, Bo Wen, Duxin Sun, James M Rae, Shaomeng Wang
Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity. Journal of medicinal chemistry (2023)